Introduction

If you follow weight loss medicine, you have probably already heard the buzz around retatrutide — a next-generation GLP-1 triple agonist that has produced weight loss results in clinical trials that surpass even semaglutide and tirzepatide. We're talking about average body weight reductions of 17–24% in some Phase 2 data. For a 250-pound person, that is 40–60 pounds.

As a plastic surgeon who has worked with post-weight-loss patients for many years — and who now has a dedicated Post-Ozempic Body Contouring program at my Dallas practice — I pay close attention to these developments. Dramatic weight loss at that scale creates real, predictable changes to the body's appearance that are worth understanding before you begin treatment.

What Is Retatrutide?

Retatrutide (LY3437943, developed by Eli Lilly) is a triple hormone receptor agonist, activating GLP-1, GIP, and glucagon receptors simultaneously. This multi-receptor approach produces more powerful metabolic effects than current dual agonists like tirzepatide (Mounjaro/Zepbound).

As of early 2026, retatrutide remains in late-stage clinical trials and has not yet received FDA approval for general use. Given the approval trajectory for previous drugs in this class, most analysts anticipate market availability within the next 1–2 years. Now is the time to educate yourself — and to plan.

Important: Retatrutide is not yet FDA-approved (as of March 2026). This blog is educational. Speak with your prescribing physician about what medications are currently available and appropriate for you.

What Are the Clinical Trials Showing?

Phase 2 data published in the New England Journal of Medicine showed participants losing an average of 17–24% of total body weight over 48 weeks — meaningfully more than semaglutide (~15%) and with favorable early comparisons to tirzepatide. At the highest dose tested, some participants lost nearly a quarter of their body weight.

That level of change is genuinely transformative. It is also the kind of change that affects how the body looks in ways that go well beyond the number on the scale.

Excess and loose skin

Skin has a finite ability to retract after being stretched. The more significant and rapid the weight loss, the more likely patients are to develop excess skin — particularly in the abdomen, inner thighs, upper arms, and breasts. At 20%+ body weight reduction, skin laxity is common, especially in patients over 40. Massive weight loss body contouring addresses these changes comprehensively.

Breast shape and volume changes
The breast is largely composed of fatty tissue. Significant weight loss almost always results in some reduction in breast size and, frequently, drooping (ptosis) as the volume decreases but the skin envelope remains. Many patients require a breast lift, augmentation, or combination procedure to restore the shape they want.

Body contour irregularities
Weight doesn't always come off evenly. Some areas respond well to GLP-1 medications; others are more resistant. This can leave behind stubborn pockets on the flanks, lower abdomen, and inner thighs even after impressive overall loss. VASER liposuction with Renuvion is our most advanced technique for addressing these resistant areas — combining ultrasonic fat removal with radiofrequency skin tightening.

Facial aging
As covered in detail in our Ozempic face blog, the face typically loses volume faster than it can contract, resulting in a hollowed, aged appearance. This effect is amplified with higher degrees of weight loss.

Surgical Options for Post-Retatrutide Body Contouring

The right procedures depend entirely on your individual results. Common options we discuss with weight loss patients:

• Abdominoplasty (tummy tuck) — addresses excess abdominal skin and muscle separation. Learn more →
• Corset tummy tuck — our advanced technique for more comprehensive abdominal reshaping. Learn more →
• Arm lift (brachioplasty) — removes loose skin from the upper arms. Learn more →
• Thigh lift — targets inner and outer thigh laxity. Learn more →
• Breast lift with or without augmentation — restores shape after volume changes. Learn more →
• VASER liposuction with Renuvion — removes resistant fat and tightens skin simultaneously. Learn more →
• Mommy makeover — for patients combining multiple procedures in one surgery. Learn more →
• Facial volume restoration — fillers or fat grafting to reverse facial aging from weight loss.

When Is It Safe to Have Surgery?

The standard recommendation is to wait until your weight has been stable for at least 3–6 months before body contouring surgery. This ensures durable results. If you are currently taking a GLP-1 medication and anticipating surgical body contouring, schedule a consultation now — even before your weight stabilizes. We can begin planning so you're ready to move forward as soon as the timing is right. We also have resources for out-of-town patients traveling to Dallas for surgery.

Financing: Major body contouring procedures can be financed. Dr. Burns' practice offers several options.

FAQ

Q: Is retatrutide available now?
As of early 2026, retatrutide is not yet FDA-approved for commercial use. It remains in late-stage clinical trials. Talk to your physician about currently available GLP-1 options.

Q: Will I definitely need surgery after this level of weight loss?
Not necessarily. It depends on your age, baseline skin elasticity, speed of loss, and where the weight comes off. Some patients are satisfied without surgery; others benefit significantly. A consultation provides a realistic picture.

Q: Does insurance cover body contouring after weight loss?
In most cases, cosmetic body contouring is not covered. Some panniculectomy procedures may qualify if excess skin causes documented medical issues. We can help you navigate this during your consultation.

Thinking ahead about body contouring? Let's plan now — before your weight stabilizes.

Dr. John L. Burns, Jr., MDBoard-Certified Plastic Surgeon

📍 Dallas, Texas
📞 214-515-0002
🌐 www.drjohnburns.com